高级检索
当前位置: 首页 > 详情页

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

文献详情

资源类型:
WOS体系:

收录情况: ◇ ESCI

单位: [1]Chinese Acad Med Sci, Natl Clin Res Ctr Canc,Peking Union Med Coll, CAMS Key Lab Translat Res Lung Canc,Canc Hosp, State Key Lab Mol Oncol,Dept Med Oncol,Natl Canc, Beijing, Peoples R China [2]Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Dept Resp Med,Shanxi Hosp,Canc Hosp, Taiyuan, Peoples R China [3]Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Peoples R China [4]Capital Med Univ, Beijing Jishuitan Hosp, Dept Orthopaed Oncol Surg, Beijing, Peoples R China [5]Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China [6]Chinese Peoples Liberat Army Gen Hosp, Med Innovat Res Ctr, Inst Translat Med, Beijing, Peoples R China [7]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China [8]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China [9]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China [10]Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Thorac Med Oncol, Hangzhou, Peoples R China [11]Zhejiang Canc Hosp, Dept Thorac Oncol, Hangzhou, Peoples R China [12]Fudan Univ, Zhongshan Hosp, Dept Resp Med, Shanghai, Peoples R China [13]Fujian Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China [14]Tianjin Med Univ Canc Inst & Hosp, Lung Canc Diag & Treatment Ctr, Natl Clin Res Ctr Canc, Dept Thorac Med Oncol,Key Lab Canc Prevent & Ther, Tianjin, Peoples R China [15]Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg Oncol, Guangzhou Inst Resp Dis & Hlth, Guangzhou, Peoples R China [16]Guangzhou Univ Chinese Med, Clin Med Coll 1, Affiliated Hosp 1, Dept Med Oncol, Guangzhou, Peoples R China [17]Sun Yat Sen Univ, Canc Ctr, Dept Radiat Oncol, Guangzhou, Peoples R China [18]Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China [19]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Peoples R China [20]Nanjing Univ, Affiliated Jinling Hosp, Dept Resp & Crit Care Med, Med Sch, Nanjing, Peoples R China [21]Peking Univ Int Hosp, Dept Oncol, Beijing, Peoples R China [22]Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai, Peoples R China [23]Nanjing Univ, Comprehens Canc Ctr, Drum Tower Hosp, Med Sch, Nanjing, Peoples R China [24]Linyi Cent Hosp, Dept Resp Med, Linyi, Shandong, Peoples R China [25]Shandong Canc Hosp, Dept Oncol, Jinan, Peoples R China [26]Xiangya Sch Med, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Med Oncol, Changsha, Peoples R China [27]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol Internal Med, Xian, Peoples R China [28]Xi An Jiao Tong Univ, Sch Publ Hlth, Xian, Peoples R China [29]Guangxi Med Univ, Affiliated Tumor Hosp, Dept Resp Oncol, Nanning, Peoples R China [30]Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian, Peoples R China [31]Peking Univ, Dept Thorac Med Oncol, Canc Hosp & Inst, Beijing, Peoples R China [32]China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China [33]Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
出处:
ISSN:

关键词: Lung cancer Bone metastasis Multi-disciplinary therapy Bone-modifying drugs

摘要:
Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seri-ously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to stan-dardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.

语种:
WOS:
中科院(CAS)分区:
出版当年[2022]版:
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2021]版:
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版]

第一作者:
第一作者单位: [1]Chinese Acad Med Sci, Natl Clin Res Ctr Canc,Peking Union Med Coll, CAMS Key Lab Translat Res Lung Canc,Canc Hosp, State Key Lab Mol Oncol,Dept Med Oncol,Natl Canc, Beijing, Peoples R China [2]Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Dept Resp Med,Shanxi Hosp,Canc Hosp, Taiyuan, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:434 今日访问量:0 总访问量:419 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)